Adocia SA
EPA:ADOC.PA
Overview | Financials
Company Name | Adocia SA |
Symbol | ADOC.PA |
Currency | EUR |
Price | 5.5 |
Market Cap | 82,725,242 |
Dividend Yield | 0% |
52-week-range | 5.11 - 12.66 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Olivier Soula M.B.A., Ph.D. |
Website | https://www.adocia.com |
An error occurred while fetching data.
About Adocia SA
Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform is designed and developed to optimize the performance of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD